Dr. Ching-Chi Hsu stands as a stalwart figure in the field of mental health, with a career spanning over three decades, dedicated to the understanding and treatment of dementia and Alzheimer's disease. His journey epitomizes commitment, expertise, and innovation in psychiatric care.
Currently serving as the Board of Director of WizcareHospital in Taichung Taiwan, and CEO of WizcareMCA, Dr. Hsu's leadership extends beyond clinical practice. He is also the Chairman of the Taiwan Medical Tourism Association, championing efforts to promote Taiwan as a destination for world-class medical care.
Dr. Hsu's formidable expertise is rooted in a robust foundation of training and extensive clinical experience. Beginning his residency at prestigious institutions like Taipei Veterans General Hospital and Kaohsiung Veterans General Hospital, he garnered invaluable insights into mental health care.
His subsequent roles as Director of the Psychosomatic Medicine Division at Taoyuan Veterans Hospital and Superintendent of Wizcare Hospital-Taichung further honed his skills in patient care and management.Taiwan's national insurance system ensures equitable access to mental health services for patients , as well as fostering practical knowledge accumulation among professionals like Dr. Hsu.
Education lies at the core of Dr. Hsu's journey, as agraduate of Kaohsiung Medical University, he pursued advanced studies at institutions such as National Taiwan University and Johns Hopkins University, culminating in a doctoral candidacy at National Tsing Hua University. His doctorate dissertation from Johns Hopkins University Bloomberg School of Public Health, The Association Between Length of Stay, Medical Expense, and Psychiatric Patient Dumping – A Study of Provider Competition under Global Budgeting in Taiwan,wasnominated as the Outstanding Dissertation Award of Academy Health USA.
Dr. Hsu's academic prowess extends to his Doctorate Dissertation from HeilongJiang University of Chinese Medicine, where he conducted groundbreaking research titled "Clinical Observation of Benefiting Qi, Nourishing Heart, Tranquillization Method in Treating Insomnia (Spleen-Heart Deficiency Type)." This pioneering study aimed to integrate ancient medical principles, as outlined in the works of the king of medicine 孫思邈, to treat sleep disorders nowadays. His innovative approach and dedication to bridging traditional wisdom with modern medical practices earned him recognition within the academic community.
As a keynote speaker at Mental Health 2024 in Paris, Dr. Ching-Chi Hsu would like to share he and his team's latest dissertation, Difference of Cerebrospinal Fluid Biomarkers and Neuropsychiatric Symptoms Profiles among Normal Cognition, Mild Cognitive Impairment, and Dementia Patient, which found the new evidence and formula, on the base of the big data from NACC National Alzheimer Cooperating Centerdata repository, by selecting over 2,000+ valid cases from over 40,000, that CSF biomarker calculations are a potential hope of Alzheimer's dementia staging.
Contact Dr. Ching-Chi Hsu at chi7hsu@gmail.com or on +886 936408608.